Development of an inactivated vaccine candidate for SARS-CoV-2

Gao, Qiang, Bao, Linlin, Mao, Haiyan, Wang, Lin, Xu, Kangwei, Yang, Minnan, Li, Yajing, Zhu, Ling +26 more·2020·Science
DOI 10.1126/science.abc1932

Cited by (1,438)

Items 801–900 of 1,438

  1. The COVID-19 Vaccine Landscape
    Till Koch, Anahita Fathi, Marylyn M. Addo · 2021 · Advances in experimental medicine and biology
  2. Immune responses induced by different vaccine platforms against coronavirus disease-19
    Eknath D. Ahire, Sanjay Jayprakash Kshirsagar · 2021 · Exploration of Immunology
  3. SARS-CoV-2 Targets and COVID-19 Vaccines
    Arthur W. Currier, Madeline C. Jeshurin, Valerie B. Sampson · 2021 · COVID
  4. Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection
    Guidenn Sulbarán, Pauline Maisonnasse, Axelle Amen, Grégory Effantin, Delphine Guilligay, Nathalie Dereuddre‐Bosquet, Judith A. Burger, Meliawati Poniman, Marloes Grobben, Marlyse Buisson et al. · 2022 · Cell Reports Medicine
  5. Th2-Oriented Immune Serum After SARS-CoV-2 Vaccination Does Not Enhance Infection In Vitro
    Ning Luan, Tao Li, Yunfei Wang, Han Cao, Xingxiao Yin, Kangyang Lin, Cunbao Liu · 2022 · Frontiers in Immunology
  6. Differences in Global Scientific Production Between New mRNA and Conventional Vaccines Against COVID-19
    Miguel Ángel Ruiz-Fresneda, Rafael Ruíz-Pérez, Carlos Ruiz-Fresneda · 2022 · Environmental Science and Pollution Research
  7. Analysis and comparison of anti-RBD neutralizing antibodies from AZD-1222, Sputnik V, Sinopharm and Covaxin vaccines and its relationship with gender among health care workers
    Hamed Zare, Hadis Rezapour, Alireza Fereidouni, Saboura Nikpour, Sara Mahmoudzadeh, Simon G. Royce, Mohammad Fereidouni · 2022 · Immunity & Ageing
  8. Avoiding culture shock with the SARS-CoV-2 spike protein
    Benjamin G. Hale · 2021 · eLife
  9. Adverse events and their association with comorbidities after first and second doses of Covishield vaccination among healthcare workers of Government owned medical colleges in Kerala
    A Remlabeevi, Thomas Mathew, G S Harikumaran Nair · 2021 · medRxiv
  10. Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates
    Kizzmekia S. Corbett, Anne P. Werner, Sarah O’ Connell, Matthew Gagné, Lilin Lai, Juan I. Moliva, Barbara J. Flynn, Angela Choi, Matthew J. Koch, Kathryn E. Foulds et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Immunogenicity and protective efficacy of BBV152: a whole virion inactivated SARS CoV-2 vaccine in the Syrian hamster model
    Sreelekshmy Mohandas, Pragya Dhruv Yadav, Anita M. Shete, Priya Abraham, Krishna Mohan Surapaneni, Gajanan N. Sapkal, Chandrashekhar Mote, Dimpal A. Nyayanit, Nivedita Gupta, V K Srini et al. · 2020
  12. The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves’ Disease
    Linghong Huang, ZhengRong Jiang, Jingxiong Zhou · 2022 · Frontiers in Endocrinology
  13. β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training
    Veronika Pilchová, Chittappen Kandiyil Prajeeth, Paula Jendrny et al. · 2023 · Journal of Virological Methods
  14. Rapid and Sensitive Detection of Inactivated SARS-CoV-2 Virus via Fiber-Optic and Electrochemical Impedance Spectroscopy Based Aptasensors
    Can Xiao, Nan Wang, Yuechao Zhao · 2024 · Biosensors
  15. The comparison of pathogenicity among SARS-CoV-2 variants in domestic cats
    Eun‐Sil Park, Yudai Kuroda, Akihiko Uda, Yoshihiro Kaku, Akiko Okutani, Akitoyo Hotta, Kango Tatemoto, Keita Ishijima, Yusuke Inoue, Michiko Harada et al. · 2024 · Scientific Reports
  16. Molecular basis of Ad5-nCoV vaccine-induced immunogenicity
    Dongyang Dong, Yutong Song, Shipo Wu, Busen Wang, Cheng Peng, Weiping Zhang, Weizheng Kong, Zheyuan Zhang, Jingwen Song, Lihua Hou et al. · 2025 · Structure
  17. Toll-like Receptor (TLR) Response in Chikungunya Virus Infection: Mechanism of Activation, Immune Evasion, and Use of TLR Agonists in Vaccine Development
    Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama–Kohara · 2025 · Vaccines
  18. Health protection of employees against SARS-CoV-2 coronavirus infection causing the COVID-19 disease – the current state of knowledge and recommendations
    Beata Świątkowska, Jolanta Walusiak‐Skorupa, Grzegorz Juszczyk · 2020 · Medycyna Pracy
  19. An Appraisal of the Current Scenario in Vaccine Research for COVID-19
    Wai Chin Chong, Dinesh Kumar Chellappan, Shakti Dhar Shukla, Gregory Mark Peterson, Rahul P. Patel, Niraj Kumar Jha, Rajaraman D. Eri, Kamal Dua, Murtaza M. Tambuwala, Madhur D. Shastri · 2021 · Viruses
  20. Interferon Inhibition Enhances the Pilot-Scale Production of Rabies Virus in Human Diploid MRC-5 Cells
    Xiao Yang, Mingming Wan, Linjun Cai, Ali Hou, Bo Sun, Yan Zhou, Feng Gao, Weiheng Su, Chunlai Jiang · 2021 · Viruses
  21. A Precision Adjuvant Approach to Enhance Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Optimized for Immunologically Distinct Vulnerable Populations
    David J. Dowling, Ofer Levy · 2022 · Clinical Infectious Diseases
  22. Predictors of poor serologic response to COVID-19 vaccine in patients with cancer: a systematic review and meta-analysis
    Wenxing Yang, Dongxue Zhang, Zhuo Li, Kui Zhang · 2022 · European Journal of Cancer
  23. On the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination
    Lorena O. Fernandes-Siqueira, Fabiana A. P. Ferreira, Bruna G. Sousa, Nathane Cunha Mebus-Antunes, Thais Cristtina Neves-Martins, Fábio C. L. Almeida, Gustavo C. Ferreira, Didier Salmon, Luciana Serrão Wermelinger, Andrea Thompson Da Poian · 2022 · Scientific Reports
  24. Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19
    Ming Hao, Dongxu Wang, Qian-Hui Xia, Shaoning Kan, Lu Chang, Huimin Liu, Zhi-Jing Yang, Wei-Wei Liu · 2022 · Frontiers in Immunology
  25. Pilot genome-wide association study of antibody response to inactivated SARS-CoV-2 vaccines
    Ping Li, Dawei Shi, Wenlong Shen · 2022 · Frontiers in Immunology
  26. Inactivated and Immunogenic SARS-CoV-2 for Safe Use in Immunoassays and as an Immunization Control for Non-Clinical Trials
    Mariana Pierre de Barros Gomes, José Linhares, Tiago Pereira Santos, Renata Carvalho Pereira, Renata Tourinho Santos, Stephanie Almeida da Silva, Marta Cristina Souza, Juliana Fernandes Amorim da Silva, Gisela Freitas Trindade, Viviane Silva Gomes et al. · 2023 · Viruses
  27. Dramatic Differences between the Structural Susceptibility of the S1 Pre- and S2 Postfusion States of the SARS-CoV-2 Spike Protein to External Electric Fields Revealed by Molecular Dynamics Simulations
    Alexander Lipskij, Claudia R. Arbeitman, Pablo Rojas · 2023 · Viruses
  28. General Characteristics of Adjuvants and Their Mechanism of Action (Part 1)
    Алпатова Наталья Александровна, Ж. И. Авдеева, Лысикова Светлана Леонидовна, O. V. Golovinskaya, Гайдерова Лидия Александровна · 2020 · Biological Products Prevention Diagnosis Treatment
  29. The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2
    Wael Alturaiki, Ayman Mubarak, Abduallah Al Jurayyan, Maged Gomaa Hemida · 2021 · Human Vaccines & Immunotherapeutics
  30. COVID-19 and Dentistry: An Updated Overview of Dental Perspectives and a Recommended Protocol for Dental Care and Emergency Dental Treatment
    Mahmoud Khaled AL-Omiri, Edward J. Lynch, Mohammad H. Al‐Shayyab, Abdullah A. Al Nazeh, Islam Abd Alraheam, Ziad A. Malkawi, Abdallah K. Alomiri, Ibrahim A. Alzoubi · 2021 · The Journal of Contemporary Dental Practice
  31. Efficacy and safety of potential vaccine candidates against coronavirus disease 2019
    Subodh Kumar, Manoj Kumar Saurabh, Vikas Maharshi · 2021 · Journal of Advanced Pharmaceutical Technology amp Research
  32. The development of China’s vaccine industry in the past decade: the perspective from drug regulatory science
    Guan-Jie Wang, Mingli Shao · 2021 · Human Vaccines & Immunotherapeutics
  33. Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters
    Sreelekshmy Mohandas, Pragya Dhruv Yadav, Anita M. Shete, Dimpal A. Nyayanit, Rajlaxmi Jain, Gajanan N. Sapkal, Chandrashekhar Mote · 2022 · Viruses
  34. Viral surface geometry shapes influenza and coronavirus spike evolution through antibody pressure
    Assaf Amitai · 2021 · PLoS Computational Biology
  35. The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection
    Mohammed A. H. Farouq, Reinaldo Acevedo, Valerie Anne Ferro, Paul Alexander Mulheran, Mohammed M. Al Qaraghuli · 2022 · International Journal of Molecular Sciences
  36. Immunogenicity and protective potential of chimeric virus-like particles containing SARS-CoV-2 spike and H5N1 matrix 1 proteins
    Jing Chen, Xu Wang, Letian Li, Lichao Yi, Yuhang Jiang, Pengfei Hao, Zhiqiang Xu, Wancheng Zou, Peiheng Li, Zihan Gao et al. · 2022 · Frontiers in Cellular and Infection Microbiology
  37. Vacunas contra la COVID-19
    Alberto J Villena · 2021 · Ambiociencias
  38. Effect of inactivated COVID-19 vaccination on intrauterine insemination cycle success: A retrospective cohort study
    Zijin Xu, Yixuan Wu, Yanshan Lin, Mingzhu Cao, Zhu Liang, Lei Li, Jiali Lin, Qian Chen, Jianqiao Liu, Haiying Liu · 2022 · Frontiers in Public Health
  39. Review of Developments in Combating COVID-19 by Vaccines, Inhibitors, Radiations, and Nonthermal Plasma
    Ihn Han, Sohail Mumtaz, Sekar Ashokkumar, Dharmendra Kumar Yadav, Eun Ha Choi · 2022 · Current Issues in Molecular Biology
  40. The immunogenicity of Alum+CpG adjuvant SARS-CoV-2 inactivated vaccine in mice
    Jie Wu Yang, Boran Li, Dongsheng Yang et al. · 2023 · Vaccine
  41. What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist
    M Palatnik · 2020 · Frontiers in Immunology
  42. Large scale production and characterization of SARS‐CoV‐2 whole antigen for serological test development
    Helena Cerutti, Veronica Ricci, Giulia Tesi · 2021 · Journal of Clinical Laboratory Analysis
  43. Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report
    Sonia R. Pagliusi, Benoit Hayman, Stephen Jarrett · 2021 · Vaccine
  44. Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome
    Chong Hyun Shin, Ki‐Hye Kim, Subbiah Jeeva, Sang‐Moo Kang · 2021 · Cells
  45. SARS-CoV2 vaccines: Slow is fast
    Douglas R. Green · 2020 · Science Advances
  46. Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response
    Nanda Kishore Routhu, Sailaja Gangadhara, Narayanaiah Cheedarla, Ayalnesh Shiferaw, Sheikh Abdul Rahman, Anusmita Sahoo, Pei‐Yong Shi, Vineet D. Menachery, Katharine A. Floyd, Stephanie Fischinger et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Severe acute respiratory syndrome coronavirus 2 for physicians: Molecular characteristics and host immunity (Review)
    Jin Shang, Lingyao Du, Ning Han, Duoduo Lv, Jiayi Wang, Hailing Yang, Lang Bai, Hong Tang · 2021 · Molecular Medicine Reports
  48. Implementation of immuno-chemoinformatics approaches to construct multi-epitope for vaccine development against Omicron and Delta SARS-CoV-2 variants
    Ali Adel Dawood · 2022 · Vacunas
  49. Case Report: Retinal Vasculitis in Two Adolescents After COVID-19 Vaccination
    Shaheeda Mohamed, Carmen K. M. Chan, Chi Wai Tsang · 2022 · Ocular Immunology and Inflammation
  50. A comprehensive overview on the transmission, pathogenesis, diagnosis, treatment, and prevention of SARS‐CoV‐2
    Yiting Zhang, Setrice Patricia Clarke, Huanwu Wu, Wenli Li, Chang Sheng Zhou, Kang Lin, Jiawen Wang, Jinzhi Wang, Ying Liang, Xin Wang et al. · 2023 · Journal of Medical Virology
  51. Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against infection with Beta or Delta variants
    Yoshikazu Honda-Okubo, R. Bowen, Mckinzee Barker, Helle Bielefeldt-Ohmann, N. Petrovsky · 2023 · Vaccine
  52. 30-Year Development of Inactivated Virus Vaccine in China
    Jinrong Shi, Ailin Shen, Yao Cheng, Chi Zhang, Xiaoming Yang · 2023 · Pharmaceutics
  53. Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution
    Charles S. P. Foster, Gregory J. Walker, Tyra Jean, Maureen Wong, Levent Brassil, Sonia R. Isaacs, Yonghui Lyu, Stuart Grant Turville, Anthony Dominic Kelleher, William D. Rawlinson · 2025 · Journal of Virology
  54. Threading the Pieces Together: Integrative Perspective on SARS-CoV-2
    Akshay Kanakan, Neha Mishra, Janani Srinivasa Vasudevan, Shweta Sahni, Azka Khan, Sachin Sharma, Rajesh Pandey · 2020 · Pathogens
  55. How chemical engineers can contribute to fight the COVID-19
    Harrson Silva Santana, Marcos R.P. de Souza, Mariana Garcia Mendonça Lopes, Johmar Souza, Renan Rodrigues de Oliveira Silva, Mauri Sérgio Alves Palma, Wilson Legnaro Volpi Nakano, Giovanni Alexsander Silva Lima, Guadalupe Munhoz, Dirceu Noriler et al. · 2020 · Journal of the Taiwan Institute of Chemical Engineers
  56. Confronting the threat of SARS‑CoV‑2: Realities, challenges and therapeutic strategies (Review)
    Ruixue Wang, Xiao‐San Luo, Fang Liu, Shuhong Luo · 2020 · Experimental and Therapeutic Medicine
  57. Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2
    Chuanjun Shu, 南京医科大学公共卫生学院，江苏 南京211166，中国, Xuan Huang, Huihao Tang, Dingding Mo, Jianwei Zhou, Cheng Deng, 南京师范大学生命科学学院，江苏 南京 210023，中国, 南京医科大学生物医学工程与信息学院，江苏 南京 211166，中国, 南京大学医学院附属金陵医院生殖医学中心，江苏 南京 211166，中国 et al. · 2021 · 动物学研究
  58. Fluorescent glycan fingerprinting of SARS2 spike proteins
    Zhengliang L. Wu, James M. Ertelt · 2021 · Scientific Reports
  59. SARS-CoV-2 Inactivation Simulation Using 14 MeV Neutron Irradiation
    Fang Liu, Zhengtong Zhong, Bin Liu · 2021 · Life
  60. Immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 with 12-dose vials: An interim analysis
    Anan Manomaipiboon, Uraporn Phumisantiphong, Jakravoot Maneerit · 2021 · Vaccine
  61. Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques
    Alexandra C. Willcox, Kevin Sung, Meghan E. Garrett, Jared Galloway, Megan A. O’Connor, Jesse H. Erasmus, Jennifer K. Logue, David W. Hawman, Helen Y. Chu, Kim J. Hasenkrug et al. · 2022 · PLoS Pathogens
  62. COVID-19 Vaccine: Review of the Mechanism of Action of Different Types of Vaccine
    Li-Ann Wong, Christina Gertrude Yap, Nowrozy Kamar Jahan, Naganathan Pillai · 2022 · OALib
  63. Ocular Inflammatory Reactions following an Inactivated SARS-CoV-2 Vaccine: A Four Case Series
    Ren JunHong, Tingting Zhang, Xiaoyue Li, Guodong Liu · 2022 · Ocular Immunology and Inflammation
  64. Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
    Tao‐Hsin Tung, Xiaoqing Lin, Yan Chen, Meixian Zhang, Jiansheng Zhu · 2022 · Human Vaccines & Immunotherapeutics
  65. Public health events emergency management supervision strategy considering citizens’ and new media’s different ways of participation
    Bingjie Lu, Lilong Zhu · 2022 · Soft Computing
  66. Virus-Like Particles of SARS-CoV-2 as Virus Surrogates: Morphology, Immunogenicity, and Internalization in Neuronal Cells
    Chandra Shekhar Kumar, Balwant Singh, Zaigham Abbas Rizvi, Hilal Ahmad Parray, Jitender Kumar Verma, Sukanya Ghosh, Amitabha Mukhopadhyay, Amit Awasthi, Tripti Shrivastava, Manidipa Banerjee · 2022 · ACS Infectious Diseases
  67. Oral Delivery of SARS-CoV-2 DNA Vaccines Using Attenuated Salmonella typhimurium as a Carrier in Rat
    Dan Zhu, Mengyue Mengyue, Aaodeng Qimuge, Bilige Bilige, Tegexi Baiyin, Temuqile Temuqile, Shana Chen, Siqin Borjigen, Huricha Baigude, Dezhi Yang · 2022 · Molecular Genetics Microbiology and Virology
  68. Advanced Vaccine Design Strategies against SARS-CoV-2 and Emerging Variants
    Jianzhong Zhang, Yutian Xia, Xuan Liu, Gang Liu · 2023 · Bioengineering
  69. Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity
    Ursino Pacheco-García, Jeanet Serafín‐López · 2023 · Vaccines
  70. The status of COVID-19 vaccines in India: A review
    Deepak Kumar Jha, Kumar Pranay, Samiksha, Amit Kumar, Niti Yashvardhini · 2023 · Vacunas
  71. The Common Systemic and Local Adverse Effects of the Sinovac COVID-19 Vaccine: An Observational Study From Pakistan
    Hira Khalid Chohan, Aisha Jamal, Muhammad Mubeen, Muhammad Ulusyar Khan, Muhammad Junaid, Musarat Khalid Chohan, Ahmad Imran, Anum Aslam, Adnan Anwar, Atif Ali Hashmi · 2023 · Cureus
  72. The In Vitro, In Vivo, and PBPK Evaluation of a Novel Lung-Targeted Cardiac-Safe Hydroxychloroquine Inhalation Aerogel
    Mo’tasem M. Alsmadi, Mays M. Jaradat, Rana Obaidat, Mohammad Alnaief, Rabab F. Tayyem, Nasir Idkaidek · 2023 · AAPS PharmSciTech
  73. Live unattenuated vaccines for controlling viral diseases, including COVID‐19
    Jiming Chen · 2020 · Journal of Medical Virology
  74. The Coronavirus Disease 2019 pandemic: how does it spread and how do we stop it?
    Xin Li, Siddharth Sridhar, Jasper Fuk‐Woo Chan · 2020 · Current Opinion in HIV and AIDS
  75. Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology
    Linsheng Zhuo, Mingshu Wang, Jing‐Fang Yang, Hong-Chuang Xu, Wei Huang, Luqing Shang, Guang‐Fu Yang · 2021 · Topics in Current Chemistry
  76. Clustering cases of Chlamydia psittaci pneumonia mimicking COVID-19 pneumonia
    Wei Zhong Zhao, Lei He, Xingzhi Xie · 2021 · World Journal of Clinical Cases
  77. A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activities
    Di Yin, Sikai Ling, Xiaolong Tian, Yang Li, Zhijue Xu, He‐wei Jiang, Xue Zhang, Xiaoyuan Wang, Yi Shi, Yan Zhang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Immune response to vaccine candidates based on different types of nanoscaffolded RBD domain of the SARS-CoV-2 spike protein
    Duško Lainšček, Tina Fink, Vida Forstnerič et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  79. Coronaviruses
    Dewald Schoeman, Bianca Gordon, Burtram Clinton Fielding · 2021 · Elsevier eBooks
  80. An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile
    Jorge A. Soto, Felipe Melo-González, Cristián Gutiérrez-Vera, Bárbara M. Schultz, Roslye V. Berríos-Rojas, Daniela Rivera-Pérez, Alejandro Piña-Iturbe, Guillermo Hoppe-Elsholz, Luisa Fernanda Duarte, Yaneisi Vázquez et al. · 2022 · medRxiv
  81. Inducing Long Lasting B Cell and T Cell Immunity Against Multiple Variants of SARS‐CoV‐2 Through Mutant Bacteriophage Qβ—Receptor Binding Domain Conjugate
    Zibin Tan, Canchai Yang, Po‐Han Lin, Sherif Ramadan, Weizhun Yang, Zahra Rashidi, Shuyao Lang, Fatemeh Shafieichaharberoud, Jia Gao, Xingling Pan et al. · 2024 · Advanced Healthcare Materials
  82. Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates
    E. Stepanova, I. Isakova-Sivak, V. Matyushenko, Daria А. Mezhenskaya, Igor Kudryavtsev, A. Kostromitina, Anna Chistiakova, A. Rak, E. Bazhenova, P. Prokopenko et al. · 2024 · Vaccines
  83. Digital Quantification and Ultrasensitive Detection of Single Influenza Virus Using Microgel-in-Droplet Enzyme-Linked Immunosorbent Assay
    Tianjiao Mao, Lang Nan, Ho Cheung Shum · 2024 · Analytical Chemistry
  84. COVID-19 Pandemic: A Compressive Review on Gender, Herd Immunity, and Physiological Mechanisms
    Tariku Sisay, Tesfaye Tolessa · 2020 · Risk Management and Healthcare Policy
  85. SARS-CoV-2 vaccines: current trends and prospects of developing plant-derived vaccines
    Balamurugan Shanmugaraj, Narach Khorattanakulchai, Waranyoo Phoolcharoen · 2021 · Elsevier eBooks
  86. COVID-19 Salgını Döneminde Aşı Milliyetçiliği ve Türkiye’nin Aşı Diplomasisi
    Barış ESEN · 2021 · Ekonomi Politika ve Finans Arastirmalari Dergisi
  87. A review on the induction of host immunity by the current COVID-19 vaccines and a brief non-pharmaceutical intervention to mitigate the pandemic
    Rashed Noor · 2022 · Bulletin of the National Research Centre/Bulletin of the National Research Center
  88. Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID‐19 cohorts by chemiluminescent immunoassays
    X. Dou, E. Wang, Ruiwei Jiang, Min Li, D. Xiong, Bao-Qing Sun, Xiu-Ming Zhang · 2022 · Immunity, Inflammation and Disease
  89. Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases
    Yongmei Liu, Jianhua Lu, Haoting Zhan, Wenfang Yuan, Xiaomeng Li, Haiyan Kang, Haolong Li, Yongliang Chen, Linlin Cheng, Xingli Sun et al. · 2023 · Virologica Sinica
  90. A Review of Clinical Trials of Cancer and Its Treatment as a Vaccine
    Chandni V. Chandarana, Anuradha Tiwari · 2023 · Reviews on Recent Clinical Trials
  91. Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine
    Chimuka Handabile, Marumi Ohno, Toshiki Sekiya et al. · 2024 · Scientific Reports
  92. Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs
    Jinyong Zhang, Peng Wang, Zhuoxin Li · 2024 · BMC Veterinary Research
  93. Boosting the immune response in COVID-19 vaccines via an Alum:CpG complex adjuvant
    Jia Ji, Tao-Ming Tang, Miaojin Zhu et al. · 2024 · Antiviral Research
  94. Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use
    Kathryn M. Edwards, Walter Albert Orenstein · 2020 · The Journal of Pediatrics
  95. Are We Ready For Covid – 19 Vaccines? – A General Side Effects Overview
    Lipika Das, Dr. Meghana A, Prolay Paul · 2021 · Journal of Current Medical Research and Opinion
  96. Exploring the room for repurposed hydroxychloroquine to impede COVID-19: toxicities and multipronged combination approaches with pharmaceutical insights
    Ankit Jain, Shiv Kumar Prajapati, Madhavi Tripathi, Ashok M. Raichur, Jagat R. Kanwar · 2021 · Expert Review of Clinical Pharmacology
  97. Optimization of Vero Cells Grown on a Polymer Fiber Carrier in a Disposable Bioreactor for Inactivated Coxsackievirus A16 Vaccine Development
    Keda Chen, Chaonan Li, Ying Wang · 2021 · Vaccines
  98. Impact of Prior Infection on Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Syrian Hamsters
    Cheng Zhang, Zhendong Guo, Nan Li, Huan Yong Cui, Keyin Meng, Lina Liu, Li Zhao, Shan Zhang, Cheng‐Feng Qin, Juxiang Liu et al. · 2021 · Frontiers in Microbiology
  99. The First Chemically-Synthesised, Highly Immunogenic Anti-SARS-CoV-2 Peptides in DNA Genotyped Aotus Monkeys for Human Use
    Manuel E. Patarroyo, Manuel A. Patarroyo, Martha Patricia Alba et al. · 2021 · Frontiers in Immunology
  100. False Coronavirus Disease 2019 Cases due to Contamination by Inactivated Virus Vaccine
    Kelvin Kai‐Wang To, Xin Li, David Christopher Lung et al. · 2021 · Clinical Infectious Diseases